Global Dendritic Cell Cancer Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 11-Dec-2018
No. of pages: 145

Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells.

Scope of the Report:

This report focuses on the Dendritic Cell Cancer Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Dendritic Cell Cancer Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Medigene

- Activarti

- Argos Therapeutics

- Batavia Bioservices

- Bellicum Pharmaceuticals

- Creagene

- DanDrit Biotech

- DCPrime

- Sanpower Corporation (Dendreon)

- Elios Therapeutics

- Immunicum

- Kiromic

- Merck

- Northwest Biotherapeutics

- Glaxo Smith Kline

- ImmunoCellular

- Tella

- Vaxil Bio

- Medigene

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- CreaVax

- Sipuleucel-T (Provenge)

- Others

Market Segment by Applications, can be divided into

- Pediatrics

- Adults

There are 15 Chapters to deeply display the global Dendritic Cell Cancer Vaccine market.

Chapter 1, to describe Dendritic Cell Cancer Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Dendritic Cell Cancer Vaccine, with sales, revenue, and price of Dendritic Cell Cancer Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Dendritic Cell Cancer Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Dendritic Cell Cancer Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Dendritic Cell Cancer Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Dendritic Cell Cancer Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Dendritic Cell Cancer Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 CreaVax
1.2.2 Sipuleucel-T (Provenge)
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Pediatrics
1.3.2 Adults
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medigene
2.1.1 Business Overview
2.1.2 Dendritic Cell Cancer Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Medigene Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Activarti
2.2.1 Business Overview
2.2.2 Dendritic Cell Cancer Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Activarti Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Argos Therapeutics
2.3.1 Business Overview
2.3.2 Dendritic Cell Cancer Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Batavia Bioservices
2.4.1 Business Overview
2.4.2 Dendritic Cell Cancer Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bellicum Pharmaceuticals
2.5.1 Business Overview
2.5.2 Dendritic Cell Cancer Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Creagene
2.6.1 Business Overview
2.6.2 Dendritic Cell Cancer Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Creagene Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 DanDrit Biotech
2.7.1 Business Overview
2.7.2 Dendritic Cell Cancer Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 DanDrit Biotech Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 DCPrime
2.8.1 Business Overview
2.8.2 Dendritic Cell Cancer Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 DCPrime Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sanpower Corporation (Dendreon)
2.9.1 Business Overview
2.9.2 Dendritic Cell Cancer Vaccine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanpower Corporation (Dendreon) Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Elios Therapeutics
2.10.1 Business Overview
2.10.2 Dendritic Cell Cancer Vaccine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Immunicum
2.11.1 Business Overview
2.11.2 Dendritic Cell Cancer Vaccine Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Immunicum Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Kiromic
2.12.1 Business Overview
2.12.2 Dendritic Cell Cancer Vaccine Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Kiromic Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Merck
2.13.1 Business Overview
2.13.2 Dendritic Cell Cancer Vaccine Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Merck Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Northwest Biotherapeutics
2.14.1 Business Overview
2.14.2 Dendritic Cell Cancer Vaccine Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Glaxo Smith Kline
2.15.1 Business Overview
2.15.2 Dendritic Cell Cancer Vaccine Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 ImmunoCellular
2.16.1 Business Overview
2.16.2 Dendritic Cell Cancer Vaccine Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 ImmunoCellular Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Tella
2.17.1 Business Overview
2.17.2 Dendritic Cell Cancer Vaccine Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Tella Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Vaxil Bio
2.18.1 Business Overview
2.18.2 Dendritic Cell Cancer Vaccine Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Vaxil Bio Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Medigene
2.19.1 Business Overview
2.19.2 Dendritic Cell Cancer Vaccine Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Medigene Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Dendritic Cell Cancer Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Dendritic Cell Cancer Vaccine Manufacturer Market Share in 2017
3.3.2 Top 6 Dendritic Cell Cancer Vaccine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Dendritic Cell Cancer Vaccine Market Analysis by Regions
4.1 Global Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Regions (2013-2018)
4.2 North America Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
4.3 Europe Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
4.5 South America Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
5 North America Dendritic Cell Cancer Vaccine by Countries
5.1 North America Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Dendritic Cell Cancer Vaccine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Dendritic Cell Cancer Vaccine Revenue and Market Share by Countries (2013-2018)
5.2 United States Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
5.3 Canada Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
5.4 Mexico Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
6 Europe Dendritic Cell Cancer Vaccine by Countries
6.1 Europe Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Dendritic Cell Cancer Vaccine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Dendritic Cell Cancer Vaccine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
6.3 UK Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
6.4 France Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
6.5 Russia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
6.6 Italy Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Dendritic Cell Cancer Vaccine by Countries
7.1 Asia-Pacific Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Dendritic Cell Cancer Vaccine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Dendritic Cell Cancer Vaccine Revenue and Market Share by Countries (2013-2018)
7.2 China Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
7.3 Japan Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
7.4 Korea Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
7.5 India Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
8 South America Dendritic Cell Cancer Vaccine by Countries
8.1 South America Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Dendritic Cell Cancer Vaccine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Dendritic Cell Cancer Vaccine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
8.3 Argentina Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
8.4 Colombia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Dendritic Cell Cancer Vaccine by Countries
9.1 Middle East and Africa Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Dendritic Cell Cancer Vaccine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Dendritic Cell Cancer Vaccine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
9.3 UAE Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
9.4 Egypt Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
9.5 Nigeria Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
9.6 South Africa Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
10 Global Dendritic Cell Cancer Vaccine Market Segment by Type
10.1 Global Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2013-2018)
10.2 CreaVax Sales Growth and Price
10.2.1 Global CreaVax Sales Growth (2013-2018)
10.2.2 Global CreaVax Price (2013-2018)
10.3 Sipuleucel-T (Provenge) Sales Growth and Price
10.3.1 Global Sipuleucel-T (Provenge) Sales Growth (2013-2018)
10.3.2 Global Sipuleucel-T (Provenge) Price (2013-2018)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2013-2018)
10.4.2 Global Others Price (2013-2018)
11 Global Dendritic Cell Cancer Vaccine Market Segment by Application
11.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2013-2018)
11.2 Pediatrics Sales Growth (2013-2018)
11.3 Adults Sales Growth (2013-2018)
12 Dendritic Cell Cancer Vaccine Market Forecast (2018-2023)
12.1 Global Dendritic Cell Cancer Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Dendritic Cell Cancer Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Dendritic Cell Cancer Vaccine Market Forecast (2018-2023)
12.2.2 Europe Dendritic Cell Cancer Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Dendritic Cell Cancer Vaccine Market Forecast (2018-2023)
12.2.4 South America Dendritic Cell Cancer Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Dendritic Cell Cancer Vaccine Market Forecast (2018-2023)
12.3 Dendritic Cell Cancer Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Dendritic Cell Cancer Vaccine Market Share Forecast by Type (2018-2023)
12.4 Dendritic Cell Cancer Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Dendritic Cell Cancer Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Dendritic Cell Cancer Vaccine Picture
Table Product Specifications of Dendritic Cell Cancer Vaccine
Figure Global Sales Market Share of Dendritic Cell Cancer Vaccine by Types in 2017
Table Dendritic Cell Cancer Vaccine Types for Major Manufacturers
Figure CreaVax Picture
Figure Sipuleucel-T (Provenge) Picture
Figure Others Picture
Figure Dendritic Cell Cancer Vaccine Sales Market Share by Applications in 2017
Figure Pediatrics Picture
Figure Adults Picture
Figure United States Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure France Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure UK Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure China Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure India Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Dendritic Cell Cancer Vaccine Revenue (Value) and Growth Rate (2013-2023)
Table Medigene Basic Information, Manufacturing Base and Competitors
Table Medigene Dendritic Cell Cancer Vaccine Type and Applications
Table Medigene Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Activarti Basic Information, Manufacturing Base and Competitors
Table Activarti Dendritic Cell Cancer Vaccine Type and Applications
Table Activarti Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table Argos Therapeutics Dendritic Cell Cancer Vaccine Type and Applications
Table Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Batavia Bioservices Basic Information, Manufacturing Base and Competitors
Table Batavia Bioservices Dendritic Cell Cancer Vaccine Type and Applications
Table Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bellicum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Type and Applications
Table Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Creagene Basic Information, Manufacturing Base and Competitors
Table Creagene Dendritic Cell Cancer Vaccine Type and Applications
Table Creagene Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table DanDrit Biotech Basic Information, Manufacturing Base and Competitors
Table DanDrit Biotech Dendritic Cell Cancer Vaccine Type and Applications
Table DanDrit Biotech Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table DCPrime Basic Information, Manufacturing Base and Competitors
Table DCPrime Dendritic Cell Cancer Vaccine Type and Applications
Table DCPrime Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanpower Corporation (Dendreon) Basic Information, Manufacturing Base and Competitors
Table Sanpower Corporation (Dendreon) Dendritic Cell Cancer Vaccine Type and Applications
Table Sanpower Corporation (Dendreon) Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Elios Therapeutics Basic Information, Manufacturing Base and Competitors
Table Elios Therapeutics Dendritic Cell Cancer Vaccine Type and Applications
Table Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Immunicum Basic Information, Manufacturing Base and Competitors
Table Immunicum Dendritic Cell Cancer Vaccine Type and Applications
Table Immunicum Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kiromic Basic Information, Manufacturing Base and Competitors
Table Kiromic Dendritic Cell Cancer Vaccine Type and Applications
Table Kiromic Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Dendritic Cell Cancer Vaccine Type and Applications
Table Merck Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Northwest Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Type and Applications
Table Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Glaxo Smith Kline Basic Information, Manufacturing Base and Competitors
Table Glaxo Smith Kline Dendritic Cell Cancer Vaccine Type and Applications
Table Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ImmunoCellular Basic Information, Manufacturing Base and Competitors
Table ImmunoCellular Dendritic Cell Cancer Vaccine Type and Applications
Table ImmunoCellular Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Tella Basic Information, Manufacturing Base and Competitors
Table Tella Dendritic Cell Cancer Vaccine Type and Applications
Table Tella Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Vaxil Bio Basic Information, Manufacturing Base and Competitors
Table Vaxil Bio Dendritic Cell Cancer Vaccine Type and Applications
Table Vaxil Bio Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Medigene Basic Information, Manufacturing Base and Competitors
Table Medigene Dendritic Cell Cancer Vaccine Type and Applications
Table Medigene Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Dendritic Cell Cancer Vaccine Sales by Manufacturer (2016-2017)
Figure Global Dendritic Cell Cancer Vaccine Sales Market Share by Manufacturer in 2016
Figure Global Dendritic Cell Cancer Vaccine Sales Market Share by Manufacturer in 2017
Table Global Dendritic Cell Cancer Vaccine Revenue by Manufacturer (2016-2017)
Figure Global Dendritic Cell Cancer Vaccine Revenue Market Share by Manufacturer in 2016
Figure Global Dendritic Cell Cancer Vaccine Revenue Market Share by Manufacturer in 2017
Figure Top 3 Dendritic Cell Cancer Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Dendritic Cell Cancer Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Global Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Global Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2013-2018)
Table Global Dendritic Cell Cancer Vaccine Sales by Regions (2013-2018)
Table Global Dendritic Cell Cancer Vaccine Sales Market Share by Regions (2013-2018)
Table Global Dendritic Cell Cancer Vaccine Revenue by Regions (2013-2018)
Figure Global Dendritic Cell Cancer Vaccine Revenue Market Share by Regions in 2013
Figure Global Dendritic Cell Cancer Vaccine Revenue Market Share by Regions in 2017
Figure North America Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure South America Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure North America Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2013-2018)
Table North America Dendritic Cell Cancer Vaccine Sales by Countries (2013-2018)
Table North America Dendritic Cell Cancer Vaccine Sales Market Share by Countries (2013-2018)
Figure North America Dendritic Cell Cancer Vaccine Sales Market Share by Countries in 2013
Figure North America Dendritic Cell Cancer Vaccine Sales Market Share by Countries in 2017
Table North America Dendritic Cell Cancer Vaccine Revenue by Countries (2013-2018)
Table North America Dendritic Cell Cancer Vaccine Revenue Market Share by Countries (2013-2018)
Figure North America Dendritic Cell Cancer Vaccine Revenue Market Share by Countries in 2013
Figure North America Dendritic Cell Cancer Vaccine Revenue Market Share by Countries in 2017
Figure United States Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Canada Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Mexico Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2013-2018)
Table Europe Dendritic Cell Cancer Vaccine Sales by Countries (2013-2018)
Table Europe Dendritic Cell Cancer Vaccine Sales Market Share by Countries (2013-2018)
Table Europe Dendritic Cell Cancer Vaccine Revenue by Countries (2013-2018)
Figure Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Countries in 2016
Figure Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Countries in 2017
Figure Germany Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure UK Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure France Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Russia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Italy Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Dendritic Cell Cancer Vaccine Sales by Countries (2013-2018)
Table Asia-Pacific Dendritic Cell Cancer Vaccine Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Dendritic Cell Cancer Vaccine Sales Market Share by Countries 2017
Table Asia-Pacific Dendritic Cell Cancer Vaccine Revenue by Countries (2013-2018)
Figure Asia-Pacific Dendritic Cell Cancer Vaccine Revenue Market Share by Countries 2017
Figure China Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Japan Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Korea Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure India Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Southeast Asia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure South America Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2013-2018)
Table South America Dendritic Cell Cancer Vaccine Sales by Countries (2013-2018)
Table South America Dendritic Cell Cancer Vaccine Sales Market Share by Countries (2013-2018)
Figure South America Dendritic Cell Cancer Vaccine Sales Market Share by Countries in 2017
Table South America Dendritic Cell Cancer Vaccine Revenue by Countries (2013-2018)
Table South America Dendritic Cell Cancer Vaccine Revenue Market Share by Countries (2013-2018)
Figure South America Dendritic Cell Cancer Vaccine Revenue Market Share by Countries in 2017
Figure Brazil Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Argentina Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Colombia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Dendritic Cell Cancer Vaccine Sales by Countries (2013-2018)
Table Middle East and Africa Dendritic Cell Cancer Vaccine Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Dendritic Cell Cancer Vaccine Sales Market Share by Countries in 2017
Table Middle East and Africa Dendritic Cell Cancer Vaccine Revenue by Countries (2013-2018)
Table Middle East and Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Countries in 2013
Figure Middle East and Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure UAE Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Egypt Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure Nigeria Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Figure South Africa Dendritic Cell Cancer Vaccine Sales and Growth Rate (2013-2018)
Table Global Dendritic Cell Cancer Vaccine Sales by Type (2013-2018)
Table Global Dendritic Cell Cancer Vaccine Sales Share by Type (2013-2018)
Table Global Dendritic Cell Cancer Vaccine Revenue by Type (2013-2018)
Table Global Dendritic Cell Cancer Vaccine Revenue Share by Type (2013-2018)
Figure Global CreaVax Sales Growth (2013-2018)
Figure Global CreaVax Price (2013-2018)
Figure Global Sipuleucel-T (Provenge) Sales Growth (2013-2018)
Figure Global Sipuleucel-T (Provenge) Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Dendritic Cell Cancer Vaccine Sales by Application (2013-2018)
Table Global Dendritic Cell Cancer Vaccine Sales Share by Application (2013-2018)
Figure Global Adults Sales Growth (2013-2018)
Figure Global Dendritic Cell Cancer Vaccine Sales, Revenue and Growth Rate (2018-2023)
Table Global Dendritic Cell Cancer Vaccine Sales Forecast by Regions (2018-2023)
Table Global Dendritic Cell Cancer Vaccine Market Share Forecast by Regions (2018-2023)
Figure North America Sales Dendritic Cell Cancer Vaccine Market Forecast (2018-2023)
Figure Europe Sales Dendritic Cell Cancer Vaccine Market Forecast (2018-2023)
Figure Asia-Pacific Sales Dendritic Cell Cancer Vaccine Market Forecast (2018-2023)
Figure South America Sales Dendritic Cell Cancer Vaccine Market Forecast (2018-2023)
Figure Middle East and Africa Sales Dendritic Cell Cancer Vaccine Market Forecast (2018-2023)
Table Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2018-2023)
Table Global Dendritic Cell Cancer Vaccine Market Share Forecast by Type (2018-2023)
Table Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2018-2023)
Table Global Dendritic Cell Cancer Vaccine Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Dendritic Cell Cancer Vaccine Market 2018, Forecast to 2023
    Published: 11-Dec-2018        Price: US 4880 Onwards        Pages: 145
    Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Scope of the Report: This report focuses on the Dendritic Cell Cancer Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type ......
  • Global Peptide Cancer Vaccine Market Research Report 2018
    Published: 04-Dec-2018        Price: US 2900 Onwards        Pages: 184
    This report studies the Peptide Cancer Vaccine market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Peptide Cancer Vaccine market by product type and applications/end industries. The major players in global Peptide Cancer Vaccine market include TapImmune BrightPath Biotherapeutics Ultimovacs Se......
  • Global and Chinese Cancer Vaccines Industry, 2018 Market Research Report
    Published: 03-Dec-2018        Price: US 3000 Onwards        Pages: 140
    The 'Global and Chinese Cancer Vaccines Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Cancer Vaccines industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer Vaccines manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its defin......
  • Global and Chinese Cancer Vaccine Industry, 2018 Market Research Report
    Published: 24-Nov-2018        Price: US 3000 Onwards        Pages: 139
    The 'Global and Chinese Cancer Vaccine Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Cancer Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definiti......
  • Global and Chinese Cervical Cancer Vaccine Industry, 2018 Market Research Report
    Published: 22-Nov-2018        Price: US 3000 Onwards        Pages: 138
    The 'Global and Chinese Cervical Cancer Vaccine Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Cervical Cancer Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cervical Cancer Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the indu......
  • Global Cancer Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 26-Oct-2018        Price: US 3480 Onwards        Pages: 134
    Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system's ability to fight against infections and diseases. It is used either as stand-alone therapies or in combination with traditional cancer therapeutics such as chemotherapy and surgery. As cancer is often associated with high mortality rate and are resistant to traditional treatments like chemotherapy and radiation, this has led to the research and development of anti-cancer immunot......
  • World - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
    Published: 23-Oct-2018        Price: US 3990 Onwards        Pages: 100
    Product coverage: vaccines for human medicine. This report provides an in-depth analysis of the global vaccine market. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2025. Country coverage: Worldwide - the report contains statistical data for 200 countries and includes det......
  • South-Eastern Asia - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
    Published: 23-Oct-2018        Price: US 3990 Onwards        Pages: 100
    Product coverage: vaccines for human medicine. This report provides an in-depth analysis of the vaccine market in South-Eastern Asia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2025. Country coverage: Brunei Darussalam, Cambodia, Indonesia, Lao People's Dem. Rep., ......
  • Eastern Asia - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
    Published: 23-Oct-2018        Price: US 3990 Onwards        Pages: 100
    Product coverage: vaccines for human medicine. This report provides an in-depth analysis of the vaccine market in Eastern Asia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2025. Country coverage: China, China, Hong Kong SAR, China, Macao SAR, Dem. People's Rep. of K......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs